Diagnostic Imaging January 20, 2025
Jeff Hall

In the second part of a two-part interview, Nina Kottler, M.D., says the transparency emphasis of the recent FDA guidance on AI-enabled software is welcome but needs to go beyond additional documentation to clarify how adjunctive AI is making its decisions.

Increased transparency is a cornerstone of the recent draft guidance from the Food and Drug Administration (FDA) on submissions for AI-enabled software. While this will result in an increased amount of documentation on the training as well as limitations for adjunctive use of AI models, Nina Kottler, M.D., maintained in a recent interview that this well-intended effort at transparency may fall short of having an impact in daily practice.

“ … Any of this documentation that the FDA is...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Interview / Q&A, Provider, Radiology, Technology, Trends
Can CT-Based AI Provide Automated Detection of Colorectal Cancer?
Radiology groups ‘look forward’ to working with new HHS Secretary RFK Jr.
Whole-body MRI radiology group Prenuvo raises $120M, launches new scan services
Radiologists debate the merits of AI for work list triage in emergency settings
Forecasting Supply and Demand in Radiology in 2055

Share This Article